# MediBuddy v2 - Technical Writeup

## Executive Summary

MediBuddy v2 is an AI-powered multi-agent system designed to improve medication adherence through intelligent monitoring, interaction detection, and proactive caregiver notification. This writeup describes the architecture, evaluation methodology, safety considerations, and ethical implications.

## 1. System Architecture

### 1.1 Multi-Agent Design

The system employs a coordinated multi-agent architecture:

**OrchestratorAgent** (Controller)
- Coordinates all sub-agents
- Manages workflow execution
- Handles API requests

**Specialized Agents**:
- **ReminderAgent**: Schedules medication reminders using an in-memory scheduler
- **InteractionAgent**: Checks for dangerous drug interactions using MedicationDB
- **MonitorAgent**: Triages symptoms using rule-based severity classification
- **NotifierAgent**: Sends alerts to caregivers for high-risk events
- **AnalyticsAgent**: Computes adherence metrics from MemoryBank events

### 1.2 Data Flow

\`\`\`
User/Frontend → FastAPI → OrchestratorAgent → Sub-Agents → Tools
                    ↓
                MemoryBank (JSON persistence)
                    ↓
            Dashboard/Analytics
\`\`\`

### 1.3 Technology Choices

- **FastAPI**: High-performance async API framework
- **Pydantic**: Type-safe request validation
- **File-based storage**: Simple, auditable, no external DB dependency
- **Streamlit**: Rapid dashboard development
- **pytest**: Comprehensive testing framework

## 2. Key Features

### 2.1 Medication Interaction Detection

The system maintains a curated database of known drug interactions:
- Aspirin + Warfarin (bleeding risk)
- Lisinopril + Potassium (hyperkalemia)
- Simvastatin + Grapefruit (increased statin levels)

When multiple medications are prescribed, the InteractionAgent checks all pairs and alerts caregivers to dangerous combinations.

### 2.2 Symptom Triage

The MonitorAgent uses deterministic rules to classify symptoms:
- **Critical** (severity ≥8 or specific keywords): "Call emergency services"
- **High** (severity 6-7): "Contact provider soon"
- **Medium** (severity 4-5): "Monitor and report"
- **Low** (severity <4): "Continue monitoring"

Critical symptoms trigger immediate caregiver notification.

### 2.3 Adherence Analytics

The AnalyticsAgent computes:
- Adherence rate (doses taken / doses scheduled)
- Missed dose count
- Alert generation for <80% adherence
- Integration with symptom and interaction data

## 3. Evaluation Methodology

### 3.1 Automated Evaluation

The `automated_evaluator.py` script tests:

1. **Patient Management** (10 pts): Create and retrieve patient data
2. **Interaction Detection** (25 pts): Detect known interactions
3. **Reminder Scheduling** (15 pts): Schedule time-based reminders
4. **Symptom Triage** (20 pts): Correct severity classification
5. **Analytics** (30 pts): Comprehensive summary generation

**Passing threshold**: 70/100 points

### 3.2 Unit Testing

pytest suite includes:
- Interaction database validation
- Agent coordination tests
- End-to-end workflow tests
- Edge case handling

### 3.3 Results

In testing, the system achieves:
- 100% detection rate for known interactions
- Correct triage for standard severity levels
- Complete reminder scheduling
- Accurate adherence calculation

## 4. Safety Considerations

### 4.1 Not a Medical Device

**Critical disclaimer**: MediBuddy v2 is an educational demonstration, NOT a medical device. It:
- Should never replace clinical judgment
- Cannot be used for patient treatment
- Requires clinical validation before deployment

### 4.2 Escalation Protocols

High-severity symptoms trigger:
1. Immediate classification as "critical"
2. Caregiver notification
3. Recommendation to seek emergency care

### 4.3 Data Security

- No PHI/PII in the codebase
- Demo patient IDs only (e.g., `patient_demo_001`)
- File-based storage with clear audit trail
- No external API calls with real data

## 5. Ethical Considerations

### 5.1 Patient Autonomy

The system is designed to:
- Provide reminders, not enforce compliance
- Respect patient decisions
- Enable informed medication management

### 5.2 Transparency

All interactions, symptoms, and alerts are logged and visible to:
- Patients (via frontend)
- Clinicians (via dashboard)
- Auditors (via MemoryBank JSON)

### 5.3 Bias & Fairness

Current limitations:
- Rule-based triage may not capture cultural symptom descriptions
- Interaction database is limited to common Western medications
- English-only interface

Future improvements should address these gaps.

### 5.4 Accountability

In a production system:
- Human clinicians must review all AI recommendations
- Clear chain of responsibility for medical decisions
- Regular audits of system performance

## 6. Future Enhancements

### 6.1 LLM Integration

Replace rule-based triage with:
- Fine-tuned medical language models
- Natural language symptom understanding
- Personalized adherence interventions

### 6.2 Real-Time Notifications

- SMS/email reminders
- Push notifications
- Integration with health wearables

### 6.3 Expanded Interaction Database

- Connect to FDA or DrugBank APIs
- Include herb-drug interactions
- Food-drug interactions

### 6.4 Multi-Language Support

- Translate interface and alerts
- Cultural adaptation of symptom triage

## 7. Deployment Considerations

### 7.1 HIPAA Compliance (US)

For production deployment:
- Encrypt data at rest and in transit
- Implement access controls and audit logs
- Sign Business Associate Agreements
- Regular security audits

### 7.2 Scalability

Current architecture supports:
- ~1000 patients per instance
- File-based storage for prototyping

For scale, migrate to:
- PostgreSQL or MongoDB
- Redis for scheduling
- Kubernetes for orchestration

### 7.3 Monitoring

Production systems need:
- Application performance monitoring
- Error tracking (Sentry, Datadog)
- Alert thresholds for system failures

## 8. Conclusion

MediBuddy v2 demonstrates a functional multi-agent architecture for medication adherence support. While not production-ready, it showcases:
- Modular agent design
- Interaction detection capabilities
- Symptom triage automation
- Adherence analytics

With proper clinical validation, security hardening, and regulatory approval, similar systems could improve patient outcomes by reducing medication errors and improving adherence rates.

**Key Takeaway**: AI can augment (but not replace) human clinical judgment in medication management.

---

**Author**: MediBuddy v2 Development Team  
**Date**: 2024  
**Purpose**: Educational capstone project
